Mesalamine intolerance mimics symptoms of active inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 34, Issue 1, 2002, Pages 73-76

  Iofel, Elizaveta ^a   Chawla, Anupama ^a   Daum, Fredric ^a   Markowitz, James ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MERCAPTOPURINE; MESALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DEFECATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; FEMALE; HEMATOCHEZIA; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIARRHEA; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MESALAMINE; SULFASALAZINE;

EID: 0036211306     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200201000-00017     Document Type: Article

References (23)

1. Bloody diarrhea - A new complication of sulfasalazine
2. Mesalamine. A review of its phamacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease
3. Salicylate induced exacerbation of ulcerative colitis
4. Mesalazine induced exacerbation of ulcerative colitis
5. Exacerbation of chronic ulcerative colitis with mesalamine
6. Sulfasalazine and salicylate-induced exacerbation of ulcerative colitis
7. Adverse effects with oral 5-aminosalicyclic acid
8. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis
9. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulfonamides
10. Mesalamine-induced hypersensitivity pneumonitis
11. Safety and tolerance of oral 5-ASA (Asacol) in the treatment of ulcerative colitis and Crohn's disease: Results of the US multicenter open label study
12. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine
13. Experience with Eudragit-S coated mesalamine (Asacol) in inflammatory bowel disease: Adverse events
14. Mesalazine-associated thrombocytopenia
15. Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalamine
16. Massive pericardial effusion in a child following the administration of mesalamine
17. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis
18. Acute pancreatitis after long-term 5-aminosalicylic acid therapy
19. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis
20. Diarrhea associated with mesalamine in a patient with chronic nongranulomatous enterocolitis
21. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
22. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds
23. 5-Aminosalicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine, or mesalazine